These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15809291)

  • 21. Multi-step binding of ADAMTS-13 to von Willebrand factor.
    Feys HB; Anderson PJ; Vanhoorelbeke K; Majerus EM; Sadler JE
    J Thromb Haemost; 2009 Dec; 7(12):2088-95. PubMed ID: 19765212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
    Cruz MA; Whitelock J; Dong JF
    Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
    Obert B; Tout H; Veyradier A; Fressinaud E; Meyer D; Girma JP
    Thromb Haemost; 1999 Nov; 82(5):1382-5. PubMed ID: 10595622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.
    Dong JF; Moake JL; Nolasco L; Bernardo A; Arceneaux W; Shrimpton CN; Schade AJ; McIntire LV; Fujikawa K; López JA
    Blood; 2002 Dec; 100(12):4033-9. PubMed ID: 12393397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
    Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
    J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
    Reiter RA; Knöbl P; Varadi K; Turecek PL
    Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1.
    Tsai HM; Sussman II; Ginsburg D; Lankhof H; Sixma JJ; Nagel RL
    Blood; 1997 Mar; 89(6):1954-62. PubMed ID: 9058716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.
    Wu JJ; Fujikawa K; McMullen BA; Chung DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18470-4. PubMed ID: 17121983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.
    Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.
    Gao W; Anderson PJ; Majerus EM; Tuley EA; Sadler JE
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19099-104. PubMed ID: 17146059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.
    Whitelock JL; Nolasco L; Bernardo A; Moake J; Dong JF; Cruz MA
    J Thromb Haemost; 2004 Mar; 2(3):485-91. PubMed ID: 15009467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
    Yoo G; Blombäck M; Schenck-Gustafsson K; He S
    Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.